nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Menopausal symptoms—Docetaxel—lung cancer	0.00449	0.00449	CcSEcCtD
Gadobutrol—Rash—Pemetrexed—lung cancer	0.00449	0.00449	CcSEcCtD
Gadobutrol—Dermatitis—Pemetrexed—lung cancer	0.00448	0.00448	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—lung cancer	0.00446	0.00446	CcSEcCtD
Gadobutrol—Rash—Gefitinib—lung cancer	0.00446	0.00446	CcSEcCtD
Gadobutrol—Dermatitis—Gefitinib—lung cancer	0.00445	0.00445	CcSEcCtD
Gadobutrol—Sweating increased—Etoposide—lung cancer	0.00429	0.00429	CcSEcCtD
Gadobutrol—Anaphylactic shock—Topotecan—lung cancer	0.00427	0.00427	CcSEcCtD
Gadobutrol—Hypersensitivity—Teniposide—lung cancer	0.00425	0.00425	CcSEcCtD
Gadobutrol—Infection—Topotecan—lung cancer	0.00424	0.00424	CcSEcCtD
Gadobutrol—Nausea—Pemetrexed—lung cancer	0.00423	0.00423	CcSEcCtD
Gadobutrol—Sweating increased—Paclitaxel—lung cancer	0.00421	0.00421	CcSEcCtD
Gadobutrol—Nausea—Gefitinib—lung cancer	0.0042	0.0042	CcSEcCtD
Gadobutrol—Infection—Erlotinib—lung cancer	0.0042	0.0042	CcSEcCtD
Gadobutrol—Hyperhidrosis—Topotecan—lung cancer	0.00413	0.00413	CcSEcCtD
Gadobutrol—Visual impairment—Irinotecan—lung cancer	0.00409	0.00409	CcSEcCtD
Gadobutrol—Vertigo—Vinorelbine—lung cancer	0.00402	0.00402	CcSEcCtD
Gadobutrol—Pollakiuria—Paclitaxel—lung cancer	0.00399	0.00399	CcSEcCtD
Gadobutrol—Palpitations—Vinorelbine—lung cancer	0.00396	0.00396	CcSEcCtD
Gadobutrol—Paraesthesia—Vinblastine—lung cancer	0.00395	0.00395	CcSEcCtD
Gadobutrol—Diarrhoea—Teniposide—lung cancer	0.00394	0.00394	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Docetaxel—lung cancer	0.00387	0.00387	CcSEcCtD
Gadobutrol—Paraesthesia—Topotecan—lung cancer	0.00384	0.00384	CcSEcCtD
Gadobutrol—Insomnia—Erlotinib—lung cancer	0.00382	0.00382	CcSEcCtD
Gadobutrol—Dyspnoea—Topotecan—lung cancer	0.00381	0.00381	CcSEcCtD
Gadobutrol—Dyspnoea—Erlotinib—lung cancer	0.00377	0.00377	CcSEcCtD
Gadobutrol—Pain—Vinblastine—lung cancer	0.00376	0.00376	CcSEcCtD
Gadobutrol—Visual impairment—Cisplatin—lung cancer	0.00371	0.00371	CcSEcCtD
Gadobutrol—Vomiting—Teniposide—lung cancer	0.00367	0.00367	CcSEcCtD
Gadobutrol—Anaphylactic shock—Vinorelbine—lung cancer	0.00365	0.00365	CcSEcCtD
Gadobutrol—Pain—Topotecan—lung cancer	0.00365	0.00365	CcSEcCtD
Gadobutrol—Rash—Teniposide—lung cancer	0.00363	0.00363	CcSEcCtD
Gadobutrol—Dermatitis—Teniposide—lung cancer	0.00363	0.00363	CcSEcCtD
Gadobutrol—Infection—Vinorelbine—lung cancer	0.00363	0.00363	CcSEcCtD
Gadobutrol—Pain—Erlotinib—lung cancer	0.00361	0.00361	CcSEcCtD
Gadobutrol—Headache—Teniposide—lung cancer	0.00361	0.00361	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vinblastine—lung cancer	0.0036	0.0036	CcSEcCtD
Gadobutrol—Hypoaesthesia—Etoposide—lung cancer	0.00351	0.00351	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Topotecan—lung cancer	0.00349	0.00349	CcSEcCtD
Gadobutrol—Abdominal pain—Vinblastine—lung cancer	0.00348	0.00348	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Erlotinib—lung cancer	0.00346	0.00346	CcSEcCtD
Gadobutrol—Hypoaesthesia—Paclitaxel—lung cancer	0.00344	0.00344	CcSEcCtD
Gadobutrol—Nausea—Teniposide—lung cancer	0.00342	0.00342	CcSEcCtD
Gadobutrol—Body temperature increased—Topotecan—lung cancer	0.00338	0.00338	CcSEcCtD
Gadobutrol—Abdominal pain—Topotecan—lung cancer	0.00338	0.00338	CcSEcCtD
Gadobutrol—Abdominal pain—Erlotinib—lung cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Body temperature increased—Erlotinib—lung cancer	0.00334	0.00334	CcSEcCtD
Gadobutrol—Visual impairment—Paclitaxel—lung cancer	0.00333	0.00333	CcSEcCtD
Gadobutrol—Vertigo—Irinotecan—lung cancer	0.00332	0.00332	CcSEcCtD
Gadobutrol—Paraesthesia—Vinorelbine—lung cancer	0.00328	0.00328	CcSEcCtD
Gadobutrol—Dyspnoea—Vinorelbine—lung cancer	0.00326	0.00326	CcSEcCtD
Gadobutrol—Hypersensitivity—Vinblastine—lung cancer	0.00324	0.00324	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—lung cancer	0.00318	0.00318	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Methotrexate—lung cancer	0.00316	0.00316	CcSEcCtD
Gadobutrol—Hypersensitivity—Topotecan—lung cancer	0.00315	0.00315	CcSEcCtD
Gadobutrol—Pain—Vinorelbine—lung cancer	0.00313	0.00313	CcSEcCtD
Gadobutrol—Anaphylactic shock—Irinotecan—lung cancer	0.00301	0.00301	CcSEcCtD
Gadobutrol—Diarrhoea—Vinblastine—lung cancer	0.00301	0.00301	CcSEcCtD
Gadobutrol—Dysgeusia—Etoposide—lung cancer	0.00301	0.00301	CcSEcCtD
Gadobutrol—Infection—Irinotecan—lung cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vinorelbine—lung cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Dysgeusia—Paclitaxel—lung cancer	0.00295	0.00295	CcSEcCtD
Gadobutrol—Anaphylactic shock—Gemcitabine—lung cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Diarrhoea—Topotecan—lung cancer	0.00292	0.00292	CcSEcCtD
Gadobutrol—Hypoaesthesia—Docetaxel—lung cancer	0.00292	0.00292	CcSEcCtD
Gadobutrol—Infection—Gemcitabine—lung cancer	0.00292	0.00292	CcSEcCtD
Gadobutrol—Hyperhidrosis—Irinotecan—lung cancer	0.00291	0.00291	CcSEcCtD
Gadobutrol—Dizziness—Vinblastine—lung cancer	0.00291	0.00291	CcSEcCtD
Gadobutrol—Convulsion—Cisplatin—lung cancer	0.00291	0.00291	CcSEcCtD
Gadobutrol—Diarrhoea—Erlotinib—lung cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Body temperature increased—Vinorelbine—lung cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Abdominal pain—Vinorelbine—lung cancer	0.00289	0.00289	CcSEcCtD
Gadobutrol—Hyperhidrosis—Gemcitabine—lung cancer	0.00284	0.00284	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—lung cancer	0.00283	0.00283	CcSEcCtD
Gadobutrol—Visual impairment—Docetaxel—lung cancer	0.00283	0.00283	CcSEcCtD
Gadobutrol—Dizziness—Topotecan—lung cancer	0.00283	0.00283	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—lung cancer	0.0028	0.0028	CcSEcCtD
Gadobutrol—Vomiting—Vinblastine—lung cancer	0.0028	0.0028	CcSEcCtD
Gadobutrol—Dizziness—Erlotinib—lung cancer	0.0028	0.0028	CcSEcCtD
Gadobutrol—Vertigo—Etoposide—lung cancer	0.00276	0.00276	CcSEcCtD
Gadobutrol—Headache—Vinblastine—lung cancer	0.00276	0.00276	CcSEcCtD
Gadobutrol—Anaphylactic shock—Cisplatin—lung cancer	0.00274	0.00274	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00273	0.00273	CcSEcCtD
Gadobutrol—Insomnia—Irinotecan—lung cancer	0.00273	0.00273	CcSEcCtD
Gadobutrol—Infection—Cisplatin—lung cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Vomiting—Topotecan—lung cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Paraesthesia—Irinotecan—lung cancer	0.00271	0.00271	CcSEcCtD
Gadobutrol—Vertigo—Paclitaxel—lung cancer	0.00271	0.00271	CcSEcCtD
Gadobutrol—Rash—Topotecan—lung cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Hypersensitivity—Vinorelbine—lung cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Dermatitis—Topotecan—lung cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Vomiting—Erlotinib—lung cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Dyspnoea—Irinotecan—lung cancer	0.00269	0.00269	CcSEcCtD
Gadobutrol—Headache—Topotecan—lung cancer	0.00268	0.00268	CcSEcCtD
Gadobutrol—Rash—Erlotinib—lung cancer	0.00267	0.00267	CcSEcCtD
Gadobutrol—Dermatitis—Erlotinib—lung cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Palpitations—Paclitaxel—lung cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Convulsion—Etoposide—lung cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Insomnia—Gemcitabine—lung cancer	0.00266	0.00266	CcSEcCtD
Gadobutrol—Headache—Erlotinib—lung cancer	0.00265	0.00265	CcSEcCtD
Gadobutrol—Hyperhidrosis—Cisplatin—lung cancer	0.00265	0.00265	CcSEcCtD
Gadobutrol—Paraesthesia—Gemcitabine—lung cancer	0.00264	0.00264	CcSEcCtD
Gadobutrol—Dyspnoea—Gemcitabine—lung cancer	0.00262	0.00262	CcSEcCtD
Gadobutrol—Nausea—Vinblastine—lung cancer	0.00261	0.00261	CcSEcCtD
Gadobutrol—Convulsion—Paclitaxel—lung cancer	0.00261	0.00261	CcSEcCtD
Gadobutrol—Pain—Irinotecan—lung cancer	0.00258	0.00258	CcSEcCtD
Gadobutrol—Nausea—Topotecan—lung cancer	0.00254	0.00254	CcSEcCtD
Gadobutrol—Pain—Gemcitabine—lung cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Nausea—Erlotinib—lung cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Dry mouth—Paclitaxel—lung cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Anaphylactic shock—Etoposide—lung cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Diarrhoea—Vinorelbine—lung cancer	0.0025	0.0025	CcSEcCtD
Gadobutrol—Dysgeusia—Docetaxel—lung cancer	0.0025	0.0025	CcSEcCtD
Gadobutrol—Infection—Etoposide—lung cancer	0.00249	0.00249	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Irinotecan—lung cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Anaphylactic shock—Paclitaxel—lung cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Paraesthesia—Cisplatin—lung cancer	0.00246	0.00246	CcSEcCtD
Gadobutrol—Infection—Paclitaxel—lung cancer	0.00244	0.00244	CcSEcCtD
Gadobutrol—Dyspnoea—Cisplatin—lung cancer	0.00244	0.00244	CcSEcCtD
Gadobutrol—Hyperhidrosis—Etoposide—lung cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Dizziness—Vinorelbine—lung cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—lung cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Body temperature increased—Irinotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Gadobutrol—Abdominal pain—Irinotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Gadobutrol—Hyperhidrosis—Paclitaxel—lung cancer	0.00238	0.00238	CcSEcCtD
Gadobutrol—Pain—Cisplatin—lung cancer	0.00234	0.00234	CcSEcCtD
Gadobutrol—Vomiting—Vinorelbine—lung cancer	0.00232	0.00232	CcSEcCtD
Gadobutrol—Body temperature increased—Gemcitabine—lung cancer	0.00232	0.00232	CcSEcCtD
Gadobutrol—Rash—Vinorelbine—lung cancer	0.0023	0.0023	CcSEcCtD
Gadobutrol—Dermatitis—Vinorelbine—lung cancer	0.0023	0.0023	CcSEcCtD
Gadobutrol—Headache—Vinorelbine—lung cancer	0.00229	0.00229	CcSEcCtD
Gadobutrol—Palpitations—Docetaxel—lung cancer	0.00226	0.00226	CcSEcCtD
Gadobutrol—Paraesthesia—Etoposide—lung cancer	0.00225	0.00225	CcSEcCtD
Gadobutrol—Dyspnoea—Etoposide—lung cancer	0.00224	0.00224	CcSEcCtD
Gadobutrol—Insomnia—Paclitaxel—lung cancer	0.00222	0.00222	CcSEcCtD
Gadobutrol—Hypersensitivity—Irinotecan—lung cancer	0.00222	0.00222	CcSEcCtD
Gadobutrol—Convulsion—Docetaxel—lung cancer	0.00221	0.00221	CcSEcCtD
Gadobutrol—Paraesthesia—Paclitaxel—lung cancer	0.00221	0.00221	CcSEcCtD
Gadobutrol—Dyspnoea—Paclitaxel—lung cancer	0.00219	0.00219	CcSEcCtD
Gadobutrol—Nausea—Vinorelbine—lung cancer	0.00217	0.00217	CcSEcCtD
Gadobutrol—Body temperature increased—Cisplatin—lung cancer	0.00216	0.00216	CcSEcCtD
Gadobutrol—Pain—Etoposide—lung cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Dry mouth—Docetaxel—lung cancer	0.00213	0.00213	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—lung cancer	0.00211	0.00211	CcSEcCtD
Gadobutrol—Pain—Paclitaxel—lung cancer	0.0021	0.0021	CcSEcCtD
Gadobutrol—Anaphylactic shock—Docetaxel—lung cancer	0.00208	0.00208	CcSEcCtD
Gadobutrol—Infection—Docetaxel—lung cancer	0.00207	0.00207	CcSEcCtD
Gadobutrol—Diarrhoea—Irinotecan—lung cancer	0.00206	0.00206	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Etoposide—lung cancer	0.00205	0.00205	CcSEcCtD
Gadobutrol—Visual impairment—Methotrexate—lung cancer	0.00204	0.00204	CcSEcCtD
Gadobutrol—Hypersensitivity—Cisplatin—lung cancer	0.00202	0.00202	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Paclitaxel—lung cancer	0.00201	0.00201	CcSEcCtD
Gadobutrol—Diarrhoea—Gemcitabine—lung cancer	0.00201	0.00201	CcSEcCtD
Gadobutrol—Dizziness—Irinotecan—lung cancer	0.00199	0.00199	CcSEcCtD
Gadobutrol—Body temperature increased—Etoposide—lung cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Abdominal pain—Etoposide—lung cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Abdominal pain—Paclitaxel—lung cancer	0.00194	0.00194	CcSEcCtD
Gadobutrol—Body temperature increased—Paclitaxel—lung cancer	0.00194	0.00194	CcSEcCtD
Gadobutrol—Vomiting—Irinotecan—lung cancer	0.00192	0.00192	CcSEcCtD
Gadobutrol—Rash—Irinotecan—lung cancer	0.0019	0.0019	CcSEcCtD
Gadobutrol—Dermatitis—Irinotecan—lung cancer	0.0019	0.0019	CcSEcCtD
Gadobutrol—Headache—Irinotecan—lung cancer	0.00189	0.00189	CcSEcCtD
Gadobutrol—Insomnia—Docetaxel—lung cancer	0.00188	0.00188	CcSEcCtD
Gadobutrol—Diarrhoea—Cisplatin—lung cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Paraesthesia—Docetaxel—lung cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Vomiting—Gemcitabine—lung cancer	0.00187	0.00187	CcSEcCtD
Gadobutrol—Dyspnoea—Docetaxel—lung cancer	0.00186	0.00186	CcSEcCtD
Gadobutrol—Rash—Gemcitabine—lung cancer	0.00185	0.00185	CcSEcCtD
Gadobutrol—Dermatitis—Gemcitabine—lung cancer	0.00185	0.00185	CcSEcCtD
Gadobutrol—Hypersensitivity—Etoposide—lung cancer	0.00185	0.00185	CcSEcCtD
Gadobutrol—Headache—Gemcitabine—lung cancer	0.00184	0.00184	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—lung cancer	0.00182	0.00182	CcSEcCtD
Gadobutrol—Hypersensitivity—Paclitaxel—lung cancer	0.00181	0.00181	CcSEcCtD
Gadobutrol—Dysgeusia—Methotrexate—lung cancer	0.0018	0.0018	CcSEcCtD
Gadobutrol—Nausea—Irinotecan—lung cancer	0.00179	0.00179	CcSEcCtD
Gadobutrol—Pain—Docetaxel—lung cancer	0.00178	0.00178	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—lung cancer	0.00176	0.00176	CcSEcCtD
Gadobutrol—Nausea—Gemcitabine—lung cancer	0.00174	0.00174	CcSEcCtD
Gadobutrol—Vomiting—Cisplatin—lung cancer	0.00174	0.00174	CcSEcCtD
Gadobutrol—Rash—Cisplatin—lung cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Dermatitis—Cisplatin—lung cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Diarrhoea—Etoposide—lung cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Docetaxel—lung cancer	0.0017	0.0017	CcSEcCtD
Gadobutrol—Diarrhoea—Paclitaxel—lung cancer	0.00168	0.00168	CcSEcCtD
Gadobutrol—Dizziness—Etoposide—lung cancer	0.00166	0.00166	CcSEcCtD
Gadobutrol—Vertigo—Methotrexate—lung cancer	0.00165	0.00165	CcSEcCtD
Gadobutrol—Abdominal pain—Docetaxel—lung cancer	0.00165	0.00165	CcSEcCtD
Gadobutrol—Body temperature increased—Docetaxel—lung cancer	0.00165	0.00165	CcSEcCtD
Gadobutrol—Dizziness—Paclitaxel—lung cancer	0.00163	0.00163	CcSEcCtD
Gadobutrol—Nausea—Cisplatin—lung cancer	0.00163	0.00163	CcSEcCtD
Gadobutrol—Convulsion—Methotrexate—lung cancer	0.00159	0.00159	CcSEcCtD
Gadobutrol—Vomiting—Etoposide—lung cancer	0.00159	0.00159	CcSEcCtD
Gadobutrol—Rash—Etoposide—lung cancer	0.00158	0.00158	CcSEcCtD
Gadobutrol—Dermatitis—Etoposide—lung cancer	0.00158	0.00158	CcSEcCtD
Gadobutrol—Headache—Etoposide—lung cancer	0.00157	0.00157	CcSEcCtD
Gadobutrol—Vomiting—Paclitaxel—lung cancer	0.00156	0.00156	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—lung cancer	0.00156	0.00156	CcSEcCtD
Gadobutrol—Rash—Paclitaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Gadobutrol—Dermatitis—Paclitaxel—lung cancer	0.00155	0.00155	CcSEcCtD
Gadobutrol—Headache—Paclitaxel—lung cancer	0.00154	0.00154	CcSEcCtD
Gadobutrol—Hypersensitivity—Docetaxel—lung cancer	0.00154	0.00154	CcSEcCtD
Gadobutrol—Anaphylactic shock—Methotrexate—lung cancer	0.0015	0.0015	CcSEcCtD
Gadobutrol—Infection—Methotrexate—lung cancer	0.00149	0.00149	CcSEcCtD
Gadobutrol—Nausea—Etoposide—lung cancer	0.00149	0.00149	CcSEcCtD
Gadobutrol—Nausea—Paclitaxel—lung cancer	0.00146	0.00146	CcSEcCtD
Gadobutrol—Hyperhidrosis—Methotrexate—lung cancer	0.00145	0.00145	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—lung cancer	0.00143	0.00143	CcSEcCtD
Gadobutrol—Diarrhoea—Docetaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—lung cancer	0.00141	0.00141	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—lung cancer	0.00138	0.00138	CcSEcCtD
Gadobutrol—Dizziness—Docetaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Gadobutrol—Insomnia—Methotrexate—lung cancer	0.00136	0.00136	CcSEcCtD
Gadobutrol—Paraesthesia—Methotrexate—lung cancer	0.00135	0.00135	CcSEcCtD
Gadobutrol—Dyspnoea—Methotrexate—lung cancer	0.00134	0.00134	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—lung cancer	0.00133	0.00133	CcSEcCtD
Gadobutrol—Vomiting—Docetaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Gadobutrol—Rash—Docetaxel—lung cancer	0.00131	0.00131	CcSEcCtD
Gadobutrol—Dermatitis—Docetaxel—lung cancer	0.00131	0.00131	CcSEcCtD
Gadobutrol—Headache—Docetaxel—lung cancer	0.00131	0.00131	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—lung cancer	0.0013	0.0013	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—lung cancer	0.00129	0.00129	CcSEcCtD
Gadobutrol—Pain—Methotrexate—lung cancer	0.00128	0.00128	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—lung cancer	0.00126	0.00126	CcSEcCtD
Gadobutrol—Nausea—Docetaxel—lung cancer	0.00124	0.00124	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Methotrexate—lung cancer	0.00123	0.00123	CcSEcCtD
Gadobutrol—Abdominal pain—Methotrexate—lung cancer	0.00119	0.00119	CcSEcCtD
Gadobutrol—Body temperature increased—Methotrexate—lung cancer	0.00119	0.00119	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—lung cancer	0.00118	0.00118	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—lung cancer	0.00117	0.00117	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—lung cancer	0.00116	0.00116	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—lung cancer	0.00111	0.00111	CcSEcCtD
Gadobutrol—Hypersensitivity—Methotrexate—lung cancer	0.00111	0.00111	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—lung cancer	0.00106	0.00106	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Gadobutrol—Diarrhoea—Methotrexate—lung cancer	0.00103	0.00103	CcSEcCtD
Gadobutrol—Dizziness—Methotrexate—lung cancer	0.000993	0.000993	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—lung cancer	0.000958	0.000958	CcSEcCtD
Gadobutrol—Vomiting—Methotrexate—lung cancer	0.000955	0.000955	CcSEcCtD
Gadobutrol—Rash—Methotrexate—lung cancer	0.000947	0.000947	CcSEcCtD
Gadobutrol—Dermatitis—Methotrexate—lung cancer	0.000946	0.000946	CcSEcCtD
Gadobutrol—Headache—Methotrexate—lung cancer	0.000941	0.000941	CcSEcCtD
Gadobutrol—Nausea—Methotrexate—lung cancer	0.000892	0.000892	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—lung cancer	0.00089	0.00089	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—lung cancer	0.00086	0.00086	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—lung cancer	0.000827	0.000827	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—lung cancer	0.00082	0.00082	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—lung cancer	0.000819	0.000819	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—lung cancer	0.000815	0.000815	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—lung cancer	0.000772	0.000772	CcSEcCtD
